Advertisement

Topics

Harbour BioMed raises $85m to accelerate growth of therapeutic pipeline

07:03 EDT 28 Aug 2018 | Pharmaceutical Business Review

Harbour BioMed is engaged in the discovery and development of therapeutics for oncology and immunological diseases. The financing round was led by GIC Private Limited, and participants included

The post Harbour BioMed raises $85m to accelerate growth of therapeutic pipeline appeared first on Pharma Business review.

Original Article: Harbour BioMed raises $85m to accelerate growth of therapeutic pipeline

NEXT ARTICLE

More From BioPortfolio on "Harbour BioMed raises $85m to accelerate growth of therapeutic pipeline"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...